Huntington Station, NJ, United States of America

Alexander L Darian

This inventor holds 36 USPTO granted patents and 3 published patent applications, plus 7 CIPO patents and 9 EPO patents, primarily in Ultrasonic Surgical Instruments. Top assignees: Misonix, Inc., Milsonix Incorporated. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander L Darian. Retrieved from https://idiyas.com/inventor/alexander-l-darian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 36 

% Patents Active = 97.2

 

 

Average Co-Inventor Count = 2.1

ph-index = 13

Forward Citations = 1,274(Granted Patents)


Location History:

  • Huntington Station, NJ (US) (2007 - 2014)
  • Huntington Station, NY (US) (2003 - 2015)
  • Brightwaters, NY (US) (2012 - 2023)

Company Filing History:


Years Active: 2003-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ultrasonic Surgical Instrument
Biofilm Formation
Minimally Invasive Surgery
Ultrasonic Probe
Ultrasonic Cutting Blade
Ultrasonic Osteotome
RF Cauterization
Medical Transducer
Surgical Apparatus
Therapeutic Ultrasound
Tissue Excision
Surgical Method
36 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alexander L. Darian

Introduction

Alexander L. Darian is an accomplished inventor based in Huntington Station, New Jersey, who has made significant contributions to the field of medical technology. With a remarkable portfolio of 35 patents, Darian has dedicated his career to developing innovative solutions that enhance surgical practices and improve patient outcomes.

Latest Patents

Among his latest inventions is a groundbreaking method for reducing biofilm formation. This two-phase methodology begins by evacuating ambient air from the surgical or treatment site, effectively extracting airborne or aerosolized bacteria that could settle on the cleansed tissue. By preventing bacterial recolonization, this approach minimizes both bacterial growth and the subsequent release of biofilm material. The second phase involves ultrasonically vibrating the patient’s tissues at the treatment site using one or more ultrasonic transducers to further disrupt any potential biofilm formation.

Another notable patent by Darian is the design of an ultrasonic medical probe with a failsafe for sterility. This ultrasonic probe features a specially designed horn or shaft, a shank for attaching to a source of ultrasonic vibratory energy, and a polymeric component that transmits ultrasonic energy yet degrades under extreme conditions. This innovative design ensures that the probe remains sterile and inoperative when necessary, enhancing safety during medical procedures.

Career Highlights

Darian has collaborated with notable companies such as Misonix, Inc. and Milsonix Incorporated, where he has contributed his expertise to advance medical technologies. His inventiveness and technical knowledge have consistently led to advancements in surgical tools and techniques, reflecting his commitment to improving healthcare.

Collaborations

Throughout his career, Alexander L. Darian has worked alongside talented individuals such as Dan Voic and Scott Isola. These collaborations have enabled him to exchange ideas and develop innovative solutions that address critical challenges in medical technology, further enriching his contributions to the field.

Conclusion

In summary, Alexander L. Darian stands out as a prolific inventor with a dedication to innovation in the medical sector. His 35 patents showcase his commitment to enhancing surgical practices and improving patient care. As he continues to develop new technologies, Darian's work remains an inspiration to fellow inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…